等待开盘 11-05 09:30:00 美东时间
-0.160
-2.42%
今日重点评级关注:韦德布什:维持Artiva Biotherapeutics"跑赢大市"评级,目标价从18美元升至23美元;巴克莱:维持Cellectis"超配"评级,目标价从4美元升至8美元
10-20 10:03
UBS analyst Arpine Kocharyan initiates coverage on Xponential Fitness (NYSE:XPOF) with a Neutral rating and announces Price Target of $8.
10-17 21:47
Xponential Fitness ( ($XPOF) ) has issued an update. On September 19, 2025, Xpo...
09-19 21:30
今日重点评级关注:RBC Capital:维持Edgewise Therapeutics"跑赢大市"评级,目标价从48美元升至49美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从6美元升至7美元
08-11 09:43
Raymond James analyst Joseph Altobello maintains Xponential Fitness (NYSE:XPOF) with a Strong Buy and lowers the price target from $15 to $14.
08-09 00:19
Gainers MEDIROM Healthcare Techs (NASDAQ:MRM) shares increased by 75.8% to $2....
08-08 20:08
Shares of Expedia Group, Inc. (NASDAQ:EXPE) rose sharply in pre-market trading ...
08-08 17:14
Xponential Fitness (NYSE:XPOF) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.22 by 18.72 percent. This is a 966.67 percent increase over losses of $(0.03) per share from
08-08 04:34
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
Xponential Fitness (NYSE:XPOF) is preparing to release its quarterly earnings o...
08-07 04:04